Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Option Award | 2024-04-17 4:32 pm | N/A 2034-04-15 | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 463,250 | $0 | 1,973,250 (Direct) | View |
| 2023-08-28 Option Award | 2023-08-30 4:45 pm | N/A 2033-08-28 | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 1,355,000 | $0 | 1,510,000 (Direct) | View |
| 2023-07-11 Exercise | 2023-07-13 7:33 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 50 | $1000 | 441,586 (Direct) | View |
| 2023-07-11 Exercise | 2023-07-13 7:33 pm | 2023-07-11 N/A | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 371,186 | $0 | 441,586 (Direct) | View |
| 2023-03-08 Option Award | 2023-03-09 9:32 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 50 | $1000 | 50 (Direct) | View |
| 2022-11-21 Option Award | 2022-11-23 08:00 am | N/A 2032-11-21 | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 55,000 | $0 | 155,000 (Direct) | View |
Ownership | 2022-11-21 08:51 am | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 0 | $0 | 170,400 (Direct) | View |